Current Editions
Tertiary lymphoid structures: Key to predicting and improving cancer immunotherapy response?
At least two companies are preparing to take inducers of tertiary lymphoid structure into the clinic
Product Development
Discovery & Translation
Science Spotlight: Platelets as targeted protein degraders
BioCentury’s roundup of translational innovations also includes ribonucleoproteins delivery and fine-tuning TCR specificity
Politics, Policy & Law
Trump, Musk sink spending bill, which aimed to extend pediatric review vouchers
Government now on brink of shutdown
Finance
Fed forecast could spell cloudy skies for biotech into 2025
Biotech likely to remain under macroeconomic pressure as Fed halves projections for interest rate cuts next year
Management Tracks
Bumpus leaving FDA
Plus: Ra capital names three new partners and updates from Anaveon, Adicet, Bio Usawa and Neopredics
BioCentury ISSN 1097-7201